APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

The long-term subjective cognitive decline risk associated with Herpes zoster infections.

Three Dyne executives leave as company reports new Duchenne drug data

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 4, 2024

What Did Legal Cannabis Lead To?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

May 26, 2024

Opinion | From Resident to Academic Attending: The Challenges Ahead

Lazarus is an adjunct professor of psychiatry. I transitioned to attending status immediately after I completed my residency. One day, I was chief resident. The

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.